Paul E Sax Selected Research

Infections

1/2021	Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial.
10/2020	Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series.
1/2020	Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials.
1/2020	Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial.
1/2019	Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD Trial.
1/2019	Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353.
1/2019	Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial.
1/2018	Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial.
1/2018	Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial.
11/2017	Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul E Sax Research Topics

Disease

27	Acquired Immunodeficiency Syndrome (AIDS) 11/2020 - 07/2004
26	Infections 01/2021 - 04/2006
18	HIV Infections (HIV Infection) 10/2020 - 09/2002
7	Coinfection 01/2020 - 06/2003
6	Viremia 11/2020 - 12/2003
6	Insulin Resistance 01/2019 - 04/2003
5	Inflammation (Inflammations) 10/2020 - 07/2012
5	Nausea 10/2020 - 06/2012
4	Weight Gain 10/2021 - 01/2020
4	Headache (Headaches) 01/2020 - 11/2017
4	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 12/2019 - 07/2011
4	Proteinuria 01/2019 - 09/2014
4	Hepatitis B 01/2018 - 12/2003
3	Dizziness (Lightheadedness) 01/2019 - 06/2012
3	Hepatitis C 11/2017 - 12/2012
3	Opportunistic Infections (Opportunistic Infection) 07/2011 - 09/2010
2	COVID-19 01/2022 - 01/2022
2	Exanthema (Rash) 01/2021 - 06/2012
2	Heart Failure 01/2020 - 01/2019
2	Pneumonia (Pneumonitis) 12/2019 - 06/2008
2	Chronic Hepatitis B 01/2019 - 11/2017
2	Lymphoma (Lymphomas) 01/2019 - 06/2004
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 07/2008
2	Fibrosis (Cirrhosis) 08/2015 - 08/2006
1	Perinatal Death 01/2021
1	Bacterial Pneumonia 10/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020
1	Substance-Related Disorders (Drug Abuse) 01/2020
1	Malaria 04/2019
1	Adenocarcinoma 01/2019
1	Sleep Wake Disorders 01/2019
1	Heart Arrest (Cardiac Arrest) 01/2019

Drug/Important Bio-Agent (IBA)

23	Emtricitabine (Emtriva)FDA Link 01/2021 - 03/2009
23	Tenofovir (Viread)FDA Link 01/2021 - 02/2007
18	efavirenz (Sustiva)FDA Link 01/2021 - 12/2009
12	dolutegravirIBA 01/2021 - 03/2016
12	RNA (Ribonucleic Acid)IBA 12/2020 - 12/2003
10	Ritonavir (Norvir)FDA Link 01/2020 - 12/2009
10	Atazanavir Sulfate (Reyataz)FDA Link 01/2019 - 12/2009
9	tenofovir alafenamideIBA 01/2021 - 09/2014
8	Protease Inhibitors (Protease Inhibitor)IBA 12/2020 - 12/2009
8	Pharmaceutical PreparationsIBA 12/2020 - 07/2009
8	lamivudine drug combination abacavir FDA Link 01/2019 - 12/2009
7	Lamivudine (Epivir)FDA Link 01/2021 - 03/2016
7	Biomarkers (Surrogate Marker)IBA 01/2019 - 09/2004
6	RacivirIBA 01/2021 - 10/2011
5	abacavir (Ziagen)FDA Link 10/2021 - 10/2008
5	Reverse Transcriptase InhibitorsIBA 12/2020 - 12/2009
5	bictegravirIBA 12/2020 - 01/2017
5	elvitegravirIBA 12/2020 - 06/2012
5	CobicistatIBA 12/2020 - 06/2012
5	Antiviral Agents (Antivirals)IBA 10/2020 - 07/2016
4	doravirineIBA 01/2021 - 01/2018
4	NucleosidesIBA 12/2020 - 08/2006
4	CreatinineIBA 01/2019 - 03/2014
4	TabletsIBA 01/2019 - 06/2012
4	Anti-Retroviral Agents (Antiretroviral Agents)IBA 07/2009 - 05/2004
3	LipidsIBA 01/2021 - 05/2004
3	IntegrasesIBA 12/2020 - 01/2018
3	Darunavir (Prezista)FDA Link 01/2020 - 01/2013
3	CholesterolIBA 01/2020 - 11/2002
3	Glucose (Dextrose)FDA LinkGeneric 06/2014 - 05/2004
3	beta-GlucansIBA 11/2013 - 06/2008
3	DNA (Deoxyribonucleic Acid)IBA 05/2010 - 06/2004
3	VaccinesIBA 05/2010 - 05/2005
2	NucleotidesIBA 12/2020 - 09/2014
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 09/2004
2	HLA-B Antigens (HLA-B)IBA 01/2020 - 10/2008
2	polyglucosanIBA 12/2019 - 07/2011
2	Mitochondrial DNA (mtDNA)IBA 01/2019 - 02/2013
2	AdiponectinIBA 01/2019 - 05/2004
2	Raltegravir Potassium FDA Link 01/2018 - 11/2017
2	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 12/2012
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2018 - 12/2012
2	Cystatin CIBA 06/2015 - 03/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2014 - 06/2007
2	Amino Acids FDA Link 12/2012 - 12/2010
1	Complement System Proteins (Complement)IBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	remdesivirIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	FumaratesIBA 01/2021
1	Zidovudine (Retrovir)FDA LinkGeneric 12/2020
1	Rilpivirine (TMC-278)IBA 12/2020
1	omadacyclineIBA 10/2020
1	ibalizumabIBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	Ribavirin (Virazole)FDA LinkGeneric 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2019
1	Antimalarials (Antimalarial Agents)IBA 04/2019
1	Testosterone (Sustanon)FDA Link 01/2019
1	P-30 composite resin (P 30)IBA 01/2019
1	beta 2-Microglobulin (beta 2 Microglobulin)IBA 01/2019

Therapy/Procedure

26	Therapeutics 12/2020 - 09/2002
11	Art Therapy 10/2021 - 09/2002
6	Highly Active Antiretroviral Therapy (HAART) 09/2010 - 04/2003
1	Noninvasive Ventilation 01/2022
1	Extracorporeal Membrane Oxygenation 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Chemoprevention 04/2019